The company reported a full-year adjusted EPS of $0.81, which exceeded guidance but fell from 2023 levels. The fourth quarter saw an adjusted loss of (-$0.05) per share, reflecting tough market ...

O-I has a dominant position in the glass container market, often controlling the majority of market share in the regions in which it operates. Alcoholic beverages (beer, wine, and spirits) account for ...

In this article, we discuss the 10 best rebound stocks to invest in now. The United States economy is in a constant state of ...

Research analysts at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for Owens & Minor in a research report issued on Monday, February 3rd. Leerink Partnrs analyst M. Cherny ...

Owens & Minor shares have been a very poor performer over the past year, losing over half of their value. Find out why I ...

Mantra (OM) has surged 52% in a month. Learn about its bullish momentum and the potential for the OM price to reach $8 in ...

Benchmark analysts maintained a Buy rating on Omnicell stock (NASDAQ:OMCL) with a consistent price target of $62.00 as the company approaches its earnings release scheduled for February 6. The target ...

Investors in Bath & Body Works, Inc. BBWI need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 21, 2025 $20 Call had some of the highest ...

Owens & Minor Inc (OMI) stock saw a decline, ending the day at $9.23 which represents a decrease of $-5.01 or -35.18% from the prior close of $14.24. The stock opened at $12.8 and touched a low of $8.

OM surged 70% to $6.29, forming a new all-time high, but profit-taking and weak adoption could challenge further gains.

Owens & Minor reduced its total debt by over $240 million, and its net debt is estimated to be in the range of $1.805 * ...

The American mass beauty incubator is focusing on its core business, including high-growth global brands and fragrances.